Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice
about
Cannabinoids as therapeutic agents in cancer: current status and future implicationsThe TRPA1 channel in migraine mechanism and treatmentUpregulation of the transient receptor potential ankyrin 1 ion channel in the inflamed human and mouse colon and its protective rolesRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationTransient receptor potential (TRP) channels: a clinical perspectiveCompromised External Validity: Federally Produced Cannabis Does Not Reflect Legal MarketsPalmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile.The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitisOverexpression of Transient Receptor Protein Cation Channel Subfamily A Member 1, Confers an Independent Prognostic Indicator in Nasopharyngeal Carcinoma.An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse.Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function.Cannabidiol in inflammatory bowel diseases: a brief overview.Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics.New insights into pharmacological tools to TR(i)P cancer up.Phytochemicals and their potential usefulness in inflammatory bowel disease.Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Macrophage-derived lipid agonists of PPAR-α as intrinsic controllers of inflammation.What is the evidence for the role of TRP channels in inflammatory and immune cells?Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance.The Role of the Endocannabinoid System in the Brain-Gut Axis.The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.The pharmacology of TRP channelsThe effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents.Purinoceptor-mediated, capsaicin-resistant excitatory effect of allyl isothiocyanate on neurons of the guinea-pig small intestine.An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund's Adjuvant Rat Model of Arthritis.
P2860
Q26866298-3BB95AAF-09B6-4F6D-8418-007BA3AE6DC3Q27016641-59DF5320-7FDE-47CE-8C06-7D4F9C7DD613Q27345472-5AE76EFB-3410-48C9-BE59-CDCD19C75A91Q30357558-CD1CD44B-3DAB-45E0-A1DE-E0284DD26223Q33562143-4DDDCDB5-94D6-4D68-B5E9-BD20CC8A1589Q33577070-3A2E4FD6-9697-4025-A7D8-993ECE8F32DEQ34571380-FEE209B7-A0DE-42EE-86C2-D2F33157439EQ34795735-4AC312DD-D0DD-43B8-BF7B-E01F0A0C5062Q34875298-0ADA0CB5-17AC-4F60-99A2-4276076C8BC1Q36784020-E02E28E8-3AE5-4A6F-A7BB-3B4ACFFA0CDDQ37067968-88132C8D-3D1E-4623-8CEF-693B55314E49Q37306421-303020A1-6BA0-470B-AD17-711B711CCCC5Q37336806-2D29411C-D3AA-43AC-AB2F-20DD4E60A4F0Q38027809-DCDC09B3-D52C-43CF-8118-9C1BB15CEC67Q38166804-7450CDCE-B810-4BEE-8D12-6C8E494B63AAQ38171864-9EA4D8A4-23BE-4C99-9803-C8C01EC41AACQ38312093-6178F015-CF4C-4F70-9E9D-B0748918E327Q38503842-EFD20D80-0185-4B0D-B4C9-80C1EC1D9547Q38639002-9F0FF74F-B770-474E-B75F-D27D8B2C74FDQ38646773-09AB3597-3F56-46AD-9E7D-BF8A7E830509Q38748394-176537DB-E3F8-4868-9F36-82DF9CFF4A1BQ38761437-71416847-629B-4CB8-8138-507CBA9E13C8Q38822341-226E1AE7-3C06-4FD6-B63E-B8CDA1B14E7CQ38937293-E3641E24-B548-49C2-960A-0A61F6538A4CQ39213927-E5DEC958-0A98-4EDF-BD1D-F26B153495AAQ42552765-5D81CE3A-EE4F-477F-B2BA-06A0E313DB1AQ42702028-D5292443-8A1F-4CAE-8536-6F012643EABDQ45024501-6F94B72E-8018-4B34-99FD-9D23EC7F6D91Q46629227-44F5DA15-AAAA-4CD7-AECC-7283F6B3E318
P2860
Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Inhibitory effect of cannabich ...... -induced hypermotility in mice
@ast
Inhibitory effect of cannabich ...... -induced hypermotility in mice
@en
Inhibitory effect of cannabich ...... -induced hypermotility in mice
@nl
type
label
Inhibitory effect of cannabich ...... -induced hypermotility in mice
@ast
Inhibitory effect of cannabich ...... -induced hypermotility in mice
@en
Inhibitory effect of cannabich ...... -induced hypermotility in mice
@nl
prefLabel
Inhibitory effect of cannabich ...... -induced hypermotility in mice
@ast
Inhibitory effect of cannabich ...... -induced hypermotility in mice
@en
Inhibitory effect of cannabich ...... -induced hypermotility in mice
@nl
P2093
P2860
P50
P921
P3181
P1476
Inhibitory effect of cannabich ...... -induced hypermotility in mice
@en
P2093
Francesca Borrelli
Francesco Capasso
Gabriella Aviello
Laura Gallo
Pierangelo Orlando
P2860
P304
P3181
P356
10.1111/J.1476-5381.2012.01879.X
P407
P577
2012-06-01T00:00:00Z